Mindfulness-Based Cognitive Therapy in a Clinical Sample of OCD Patients
- Conditions
- Obsessive-Compulsive Disorder
- Interventions
- Behavioral: Mindfulness-Based Cognitive Therapy (MBCT)
- Registration Number
- NCT02217995
- Lead Sponsor
- Sunnybrook Health Sciences Centre
- Brief Summary
Obsessive Compulsive Disorder (OCD) is a chronic and debilitating disorder known to have reported lifetime prevalence in the range of 2%. OCD is most commonly treated with Cognitive Behavioural Therapy (CBT) and/or pharmacotherapy. However, some studies suggest challenges with CBT in retaining gains long term, and while 60-80% of OCD patients respond to SRI treatment, partial symptom reduction is substantial. Investigations into the effectiveness of alternative, cost-effective treatment modalities are thus needed. Mindfulness, defined as paying attention in a particular way (on purpose, in the present moment and nonjudgmentally), promotes awareness and attention to internal experience and has been shown to reduce symptoms of anxiety and depression. A number of controlled studies have found Mindfulness-Based Cognitive Therapy (MBCT) to be effective for depression, social anxiety disorder, and generalized anxiety disorder, but few have tested its effect on obsessive compulsive disorder (OCD). Moreover, those studies examining MBCT in OCD focused on clinical case studies and non-clinical samples. This study proposes to examine the effect of MBCT in clinical practice, in a randomized sample of patients with OCD whom are on a clinic wait list. As patients are allocated to the wait list, they will be randomly assigned to receive either 10 weeks of group MBCT or wait list as per usual. It is hypothesized that subjects randomly assigned to the MBCT treatment group, compared to those in the wait list control group, will see greater reductions in self-reported measures of OCD symptom severity and improvement in other measures of mindfulness, mood and level of functioning. The results of this pilot study, if successful, will provide evidence towards another route by which patients can improve their OCD while waiting for clinic services or consultation. Results will also lend more evidence as to whether MBCT is effective as a stand-alone treatment for clinical OCD, which will inform further investigations into the potential addition of mindfulness techniques to standard care.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 32
- Referred for treatment services at the Frederick W. Thompson Anxiety Disorder Centre at Sunnybrook Health Sciences Centre
- Primary Diagnosis of OCD
- Ability to communicate in written and spoken English
- Those with active substance abuse/dependence within 3 months
- Suspected organic pathology
- Recent suicide attempt/active suicidality
- Current self-injurious behaviour
- Active bipolar or psychotic disorder
- Previous completion of an MBCT course (≥ 8 weeks)
- Previous completion of an OCD-specific course of CBT (≥ 8 weeks)
- Previous completion of a general course of CBT (≥ 8 weeks) in the past 3 years
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Arm && Interventions
Group Intervention Description Mindfulness-Based Cognitive Therapy (MBCT) Mindfulness-Based Cognitive Therapy (MBCT) MBCT will be delivered in ten 2.5 hour group sessions with 15 participants per group.
- Primary Outcome Measures
Name Time Method Change in Symptom Severity from Baseline in OCD Measures 10 weeks OCD measures will include: a self-report version of the Yale-Brown Obsessive Compulsive Scale (YBOCS-SR), the Obsessive Compulsive Inventory -Revised (OCI-R), consisting of six subscales (Washing, Checking, Ordering, Obsessing, Hoarding and Neutralising), and the Obsessive Beliefs Questionnaire-44 (OBQ-44), a measure of three OCD-related belief domains (Perfectionism/Certainty, Importance/Control of thoughts, and Responsibility/Threat estimation)
- Secondary Outcome Measures
Name Time Method Change in Mindfulness from Baseline 10 weeks Mindfulness measures include: The Five Facet Mindfulness Questionnaire (FFMQ), used to measure the five constructs central to mindfulness (Observing, Describing, Acting with Awareness, Non-judgment of Inner Experience, and Non-reactivity to Inner Experience), and the the Self-Compassion Scale-Short Form (SCS-SF) measuring 6 components of self-compassion (Self-Kindness, Self-Judgment, Common Humanity, Isolation, Mindfulness \& Over-Identification).
Change in Level of Impairment from Baseline 10 weeks The Sheehan Disability Scale will be used to measure level of functional impairment in three inter-related domains (work/school, social and family life).
Change in Mood from Baseline 10 weeks The Beck Depression Inventory -II (BDI-II), will be used to assess depression severity.
Retention of Gains at Follow-up 16 weeks All self-report measures will be re-administered at 6-week follow-up to measure robustness of gains post-treatment.
Trial Locations
- Locations (1)
The Frederick W. Thompson Anxiety Disorders Centre, Sunnybrook Health Sciences Centre
🇨🇦Toronto, Ontario, Canada